1Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consen- sus conference [J]. Arthritis Rheumatism, 1994, 37 ( 2 ) : 187-192.
2Savige J, Davies D, Falk RJ, et al. Antineutrophil cytoplas- mic antibodies and associated diseases: a review of the clinical and laboratory features[-J]. Kidney Int, 2000,57 (3):846 -862.
4Ormerod AS, Cook MC. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south - eastern New South Wales. Intern Med, 2008,38(11) : 816 - 23.
5Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg - Strauss syndrome. A prospective study in 342 patients. Medicine(Baltimore), 1996,75 ( 1 ) : 17 - 28.
6Gayraud M, Guillevin L, le Toumelin P, et al. Long- term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg - Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum, 2001,44 ( 3 ) : 666 - 675.
8Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients Ann. Intern Med, 1992,116(6) :488 - 498.
9Guillevin L, Cordier JF, Lhote F, et al. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophospharnide in the treatment of generalized Wegener' s granulomatosis. Arthritis Rheum, 1997,40(12) :2187 - 2198.
10Reinhold - Keller E, Warnatz K. Z Cyelophospharnide versus bolus in Wegener's granulomatosis and other ANCA- related vasculitides: Advantages and disadvantages. Rheumatol, 2008.19.
6Winters M J, Hurley RM, Lirenman DS. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil [J]. Pediatr Nephml, 2002, 17(4) : 257-260.
7Fuieda M, Hattori M, Kurayama H, et al. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody- positive glomerulonephritis associated with propyhhiouracil treatment [J]. J Am Soc Nephrol, 2002, 13(2) : 437-445.
8Yamada A, Sato K, Hara M, et al. Propylthiouracail-induced lupus like syndrome developing in a Graves' patient with a sibling with systemic lupus erythematosus [J]. Intern Med, 2002, 41 (12) : 1204-1208.
9Herlin T, Birkebaek NH, Wolthers OD, et al. Antineutrophil cytoplasmic autoantibody (ANCA) profiles in propylthiouracil- induced lupus-like manifestations in monozygotic triplets with hyperthyroidism [J]. Scand J Rheumatol, 2002, 31 ( 1 ) : 46-49.
10Herlin T, Birkebaek NH, Wohhers OD, et al. Anti-neutrophil cytoplasmic autoantibody (ANCA) profiles in propylthiouracil- induced lupus-like manifestations in monizygotic triplets with hyperthyroidism [J]. Scand J Rheumatol, 2002, 31(1): 46-49.
